
Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial
A conversation with Paul Goode, Ph.D., president and CEO, Glucotrack Roughly 2.4 million people in the U.S. use a continuous blood glucose monitor (CBGM). Sometimes, patients who wear them experience undesired effects, such as painful sensor insertion, …